Rac1 Protein Signaling Is Required for DNA Damage Response Stimulated by Topoisomerase II Poisons
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rac1 Protein Signaling Is Required for DNA Damage Response Stimulated by Topoisomerase II Poisons
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 46, Pages 38590-38599
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2012-09-26
DOI
10.1074/jbc.m112.377903
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
- (2014) Tomáš Šimůnek et al. Pharmacological Reports
- Genotoxicity of dietary, environmental and therapeutic topoisomerase II poisons is uniformly correlated to prolongation of enzyme DNA residence
- (2011) Faiza M. Kalfalah et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity
- (2011) J Huelsenbeck et al. Cell Death & Disease
- Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
- (2010) Y. Zhao et al. CANCER RESEARCH
- Pleiotropic Effects of Statins
- (2010) Qian Zhou et al. CIRCULATION JOURNAL
- Tiam1-Rac Signaling Counteracts Eg5 during Bipolar Spindle Assembly to Facilitate Chromosome Congression
- (2010) Simon A. Woodcock et al. CURRENT BIOLOGY
- A minority of foci or pan-nuclear apoptotic staining of H2AX in the S phase after UV damage contain DNA double-strand breaks
- (2010) S. de Feraudy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pretreatment with Statin Attenuates the Cardiotoxicity of Doxorubicin in Mice
- (2009) A. Riad et al. CANCER RESEARCH
- Importance of Rac1 Signaling Pathway Inhibition in the Pleiotropic Effects of HMG-CoA Reductase Inhibitors
- (2009) Mamunur Rashid et al. CIRCULATION JOURNAL
- Targeting the Mevalonate Pathway for Improved Anticancer Therapy
- (2009) G. Fritz CURRENT CANCER DRUG TARGETS
- Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity
- (2009) Masashi Yoshida et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Topoisomerase II -dependent and -independent apoptotic effects of dexrazoxane and doxorubicin
- (2009) T. Yan et al. MOLECULAR CANCER THERAPEUTICS
- The Nuclear Import of the Small GTPase Rac1 is Mediated by the Direct Interaction with Karyopherin α2
- (2009) Kirstin Sandrock et al. TRAFFIC
- An Isoform-Selective, Small-Molecule Inhibitor Targets the Autoregulatory Mechanism of p21-Activated Kinase
- (2008) Sean W. Deacon et al. CHEMISTRY & BIOLOGY
- Statins Use a Novel Nijmegen Breakage Syndrome-1–Dependent Pathway to Accelerate DNA Repair in Vascular Smooth Muscle Cells
- (2008) Melli Mahmoudi et al. CIRCULATION RESEARCH
- Supreme EnLIGHTenment: Damage Recognition and Signaling in the Mammalian UV Response
- (2008) Peter Herrlich et al. MOLECULAR CELL
- -H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin
- (2008) A. Kinner et al. NUCLEIC ACIDS RESEARCH
- Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide
- (2006) J Damrot et al. BRITISH JOURNAL OF PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started